Medication Reconciliation in Hospitalized CKD Patients : a Quasi-Experimental Study

Not Applicable

Completed

• Conditions: Chronic Kidney Disease(CKD)

• Registration Number: NCT06819527
• Lead Sponsor: Jordan University of Science and Technology

Brief Summary

This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-01
• Primary Completion: 2023-08-30
• Study Completion: 2023-08-30
• Status Verified: 2025-02
• Study First Submitted: 2025-02-05
• Study First Submitted QC: 2025-02-05
• Last Update Submitted: 2025-02-05
• Study First Posted: 2025-02-11
• Last Update Posted: 2025-02-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 323

Inclusion Criteria

Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours.

Exclusion Criteria

Patients with kidney transplantation . Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave, and those who refused to provide a written informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Primary Outcome Measures

Name	Time	Method
all-cause 90-day readmission	90 days after discharge	The primary outcome in this study was the likelihood of all-cause 90-day readmission as extracted from medical records for both study groups

Trial Locations

Locations (1)

King Abdullah University Hospital and Princess Basma Hospital; 🇯🇴 Irbid, Jordan